| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Amgen Inc.(AMGN) | 616,539 | $136.9M | 5.36% |
| 2 | Johnson & Johnson(JNJ) | 721,779 | $119.5M | 4.68% |
| 3 | Gilead Sciences, Inc.(GILD) | 1,533,884 | $118.2M | 4.63% |
| 4 | Regeneron Pharmaceuticals, Inc.(REGN) | 161,418 | $116.0M | 4.54% |
| 5 | Vertex Pharmaceuticals Inc.(VRTX) | 318,043 | $111.9M | 4.38% |
| 6 | Eli Lilly and Company(LLY) | 213,352 | $100.1M | 3.92% |
| 7 | Unitedhealth Group Inc.(UNH) | 206,961 | $99.5M | 3.89% |
| 8 | Merck & Co., Inc.(MRK) | 728,154 | $84.0M | 3.29% |
| 9 | AbbVie Inc.(ABBV) | 545,629 | $73.5M | 2.88% |
| 10 | Biogen Inc.(BIIB) | 247,943 | $70.6M | 2.76% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Unclassified | 10.39% | 9.27% | -1.12% |
| Healthcare | 88.14% | 89.14% | +1% |
| Real Estate | 1.47% | 1.58% | +0.11% |
Quarter-over-quarter weight changes by market cap
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Large Cap | 60.22% | 60.39% | +0.17% |
| Mega Cap | 20.21% | 21.38% | +1.17% |
| Unclassified | 10.39% | 9.27% | -1.12% |
| Mid Cap | 5.94% | 6.31% | +0.37% |
| Small Cap | 2.91% | 2.26% | -0.65% |
| Micro Cap | 0.33% | 0.38% | +0.05% |
Quarter-over-quarter position changes